Accession Number: | 0000899243-21-036342 |
Date: | 2021-09-14 |
Issuer: | MAGENTA THERAPEUTICS, INC. (MGTA) |
Original Submission Date: |
OLSON LISA
C/O MAGENTA THERAPEUTICS, INC.
100 TECHNOLOGY SQUARE
CAMBRIDGE, MA 02139
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-09-14 | A | 20,000 | a | $0.00 | 20,000 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | on february 11, 2021, the reporting person was granted 40,000 restricted stock units. the restricted stock units vest in two equal installments subject to the achievement of certain performance milestones related to the issuer's business plans. the first performance milestone was achieved, resulting in vesting of 20,000 restricted stock units and the corresponding issuance of 20,000 shares of issuer common stock. |